Clinical Trial Details

Trial ID: L0644
Source ID: IRCT201212052602N8
Associated Drug: L-carnitine
Title: Study of the Serum levels of miRNA-16, miRNA-21, miRNA-217 and effects of L-carnitine on their levels , TNF-a , TGF-?? cytokines, Malondialdehyde and CRP in Nonalcoholic Steatohepatitis (NASH) patients under weight loss regimen
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nonalcoholic steatohepatitis. <br>Nonalcoholic steatohepatitis( NASH);Nonalcoholic steatohepatitis( NASH)
Interventions: Intervention 1: . Intervention group receives 2000 mg of L-carnitine as 2 vials,before the meals, for 12 weeks. Intervention 2: Control group receives 2000 mg of Placebo as 2 vials,before the meals, for 12 weeks.;Treatment - Drugs;Treatment - Drugs;. Inte
Outcome Measures: TNF-a. Timepoint: At first of the study and 12th week. Method of measurement: labratory kit.;TGF-??. Timepoint: At first of the study and 12th week. Method of measurement: Sandwich Elisa.;Malondialdehide. Timepoint: At first of the study and 12th week. Method of measurement: Sandwich Elisa.;CRP. Timepoint: At first of the study and 12th week. Method of measurement: labratory kit.;MiRNA-16. Timepoint: At first of the study and 12th week. Method of measurement: RT-PCR.;MiRNA-21. Timepoint: At first of the study and 12th week. Method of measurement: RT-PCR.;MiRNA-217. Timepoint: At first of the study and 12th week. Method of measurement: RT-PCR.nan
Sponsor/Collaborators: Vice Chancellor for Research of Tehran University of Medical Sciences
Gender: All
Age: 18 years65 years
Phases: Not applicable
Enrollment: 92
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 04/02/2013
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/2379